GlassScriptPhysician profile
Samita Chandi
NPI 1780259853
$690.93
in general payments reported to CMS, 2019-2025
8 companies · $29.45 in 2025
The $29.45 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $450 · 2024: $211 · 2025: $29.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $691.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $690.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $173.86 | 2023-2025 | Aristada, Aristada Initio, Lybalvi |
| Abbvie INC. | $166.87 | 2023-2024 | Vraylar |
| Teva Pharmaceuticals USA, INC. | $119.61 | 2023 | Austedo Xr |
| Otsuka America Pharmaceutical, INC. | $69.44 | 2023-2024 | Abilify Asimtufii, Rexulti, Abilify Maintena |
| Axsome Therapeutics, INC. | $67.12 | 2023-2024 | Auvelity |
| Vanda Pharmaceuticals INC. | $62.59 | 2023 | Fanapt, Hetlioz |
| Noven Therapeutics, LLC | $16.93 | 2024 | Secuado |
| Tris Pharma INC | $14.51 | 2024 | Dyanavel Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samita Chandi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.